Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
23.05.24
/
50%
€44.80
Target price
23.05.25
€64.64
Performance (%)
-7.59%
Price
20.06.24
€41.40
Summary
This prediction is currently active. With a performance of -7.59%, the BUY prediction for Crinetics Pharmaceuticals Inc by Morgan_Stanley is down slightly. This prediction currently runs until 23.05.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Crinetics Pharmaceuticals Inc | -2.358% |
iShares Core DAX® | 1.080% |
iShares Nasdaq 100 | 0.362% |
iShares Nikkei 225® | -1.155% |
iShares S&P 500 | 0.806% |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Morgan Stanley from $50.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat